View of Treatment patterns and clinical outcomes in chronic myeloid leukemia treated with second-line nilotinib—association of molecular milestones and prognostic scores with deep molecular response: a real-world retrospective cohort study

Return to Article Details Treatment patterns and clinical outcomes in chronic myeloid leukemia treated with second-line nilotinib—association of molecular milestones and prognostic scores with deep molecular response: a real-world retrospective cohort study Download Download PDF